Fish Oil Supplements and Cholesterol Levels: New Expert Guidelines

For years, fish oil supplements have been a staple in many households, touted as a simple way to support heart health. However, a significant shift in medical recommendations is underway, with new US guidelines casting serious doubt on their efficacy for managing cholesterol. Rzeczpospolita, as a publication deeply invested in the well-being of its Polish readers, highlights these evolving health insights. The latest guidance, issued in 2026, explicitly advises against using over-the-counter fish oil supplements to control cholesterol levels. This marks a departure from previous recommendations that did not specifically address dietary supplements. The core message is clear: these supplements are not a potent tool for reducing LDL cholesterol, often referred to as 'bad' cholesterol. Furthermore, the guidelines suggest that relying on them could be a costly mistake, both financially and in terms of health outcomes. While prescription-grade fish oil (icosapent ethyl) still holds a place in specific treatment regimens, the widely available supplements are now under scrutiny. This development underscores the importance of consulting healthcare professionals and relying on evidence-based treatments rather than anecdotal benefits or marketing claims, a principle that resonates strongly with our commitment to providing accurate health information.

“

There is a lot of evidence that clearly shows that dietary supplements are a waste of time and money in the context of treating high cholesterol and trying to lower the risk of heart attack and stroke.